Insecticides (India) Ltd

Net profit of Insecticides India rose 17.70% to Rs 58.11 crore in the quarter ended June 2025 as against Rs 49.37 crore during the previous quarter ended June 2024. Sales rose 5.24% to Rs 691.13 crore in the quarter ended June 2025 as against Rs 656.69 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales691.13656.69 5 OPM %12.2410.98 - PBDT84.7773.16 16 PBT77.4566.01 17 NP58.1149.37 18 Powered by Capital Market - Live

Insecticides India will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

Insecticides India announced that the 28th Annual General Meeting(AGM) of the company will be held on 12 August 2025.Powered by Capital Market - Live

Profit before tax (PBT) stood at Rs 22.02 crore in Q4 FY25, up 527% year-on-year. EBITDA came in at Rs 28.47 crore, up 226% YoY. For the full year FY25, net profit rose 39% to Rs 142.02 crore, while revenue from operations rose 2% to Rs 1,999.95 crore. EBITDA rose 36% to Rs 221.22 crore, and PBT rose 46% to Rs 192.77 crore compared to FY24. The company's consolidated net cash from operating activities stood at Rs 93.45 crore in FY25, as against Rs 186.97 crore in FY24. The company said it launched 11 new products in FY25 including patented latest technology products. It also successfully completed a buyback of 500,000 fully paid-up equity shares at Rs 1,000 per share, totaling Rs 50 crore. Rajesh Kumar Aggarwal, MD of Insecticides (India) said: We are pleased to report a robust performance of the Company, marked by strong execution and strategic discipline. The overall business environment remained favorable throughout the year. A good monsoon and healthy reservoir levels provided strong tailwinds for rural demand and agri-input consumption. Additionally, stable raw material prices and our deep farmer connect further supported steady demand across markets. Our continued focus on premiumization yielded positive results, driving an improvement in gross margins. We consciously prioritized value over volume, reflecting our long-term strategy of sustainable, profitable growth. Looking ahead, we remain optimistic about the upcoming seasons. We expect continued momentum supported by favorable macro tailwinds such as a strong monsoon forecast and stable raw material prices. Our growth outlook remains intact, with expectations of expansion in premium products, stable gross profit margins, and EBITDA improvement, driven by new launches and operational efficiencies. Insecticides (India) is a crop protection and Nutrition company. It boasts a product portfolio consisting of 20+ technical products and 140+ formulation products. Powered by Capital Market - Live

Net profit of Insecticides India rose 78.99% to Rs 13.89 crore in the quarter ended March 2025 as against Rs 7.76 crore during the previous quarter ended March 2024. Sales rose 31.71% to Rs 358.92 crore in the quarter ended March 2025 as against Rs 272.50 crore during the previous quarter ended March 2024. For the full year,net profit rose 38.73% to Rs 142.02 crore in the year ended March 2025 as against Rs 102.37 crore during the previous year ended March 2024. Sales rose 1.71% to Rs 1999.95 crore in the year ended March 2025 as against Rs 1966.39 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales358.92272.50 32 1999.951966.39 2 OPM %7.933.27 -11.068.27 - PBDT29.1911.37 157 221.92161.44 37 PBT22.023.77 484 192.77132.19 46 NP13.897.76 79 142.02102.37 39 Powered by Capital Market - Live

Insecticides India will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

Net profit of Insecticides India rose 41.10% to Rs 17.37 crore in the quarter ended December 2024 as against Rs 12.31 crore during the previous quarter ended December 2023. Sales declined 0.07% to Rs 357.70 crore in the quarter ended December 2024 as against Rs 357.94 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales357.70357.94 0 OPM %8.647.27 - PBDT29.8624.49 22 PBT22.2817.07 31 NP17.3712.31 41 Powered by Capital Market - Live

Insecticides (India) (IIL) has launched, a new revolutionary Insecticide, Centran. This will be a pioneering solution for tackling stem borers in paddy. With its dual-action formula, Centran effectively controls stem bores and help the farmers to achieve healthier crops and better productivity. Paddy is the backbone of the Indian farmers. Stem borers pose a significant threat to their hard work. To address this, new age insecticide Centran has been developed by the R&D Team of Insecticides (India). Centran is a unique blend of dual active ingredients for pest control and crop nourishment. The product supports robust root development, improves tiller growth, and delivers superior yields, ensuring a higher return on investment for growers.Powered by Capital Market - Live

Insecticides India will hold a meeting of the Board of Directors of the Company on 10 February 2025.Powered by Capital Market - Live

The Board of Insecticides India at its meeting held on 11 November 2024 has approved to make an investment in Kaeros Research by acquiring to equity share capital of 100% of the Issued and paid-up share capital of the Target Company from its existing shareholders (i.e. Rajesh Kumar Aggarwal, Sanskar Aggarwal and Nikunj Aggarwal), subject to the compliances with the Companies Act, 2013, SEBI Listing Regulations and other applicable laws and such other regulatory/ statutory approvals, as may be required.Powered by Capital Market - Live